141 related articles for article (PubMed ID: 12042986)
21. An out-patient second-line chemotherapy with gemcitabine and vinorelbine in patients with non-small cell lung cancer previously treated with cisplatin-based chemotherapy. A phase II study of the Hellenic co-operative Oncology Group.
Pectasides D; Kalofonos HP; Samantas E; Nicolaides C; Papacostas P; Onyenadum A; Visvikis A; Skarlos D; Fountzilas G
Anticancer Res; 2001; 21(4B):3005-10. PubMed ID: 11712802
[TBL] [Abstract][Full Text] [Related]
22. Ifosfamide and vinorelbine as first-line chemotherapy for advanced non-small cell lung carcinoma.
Vallejo C; Romero A; Perez J; Cuevas M; Lacava J; Sabatini C; Dominguez M; Rodriguez R; Barbieri M; Romero Acuña L; Romero Acuña J; Langhi M; Amato S; Salvadori M; Ortiz E; Machiavelli M; Leone B
Am J Clin Oncol; 1996 Dec; 19(6):584-8. PubMed ID: 8931677
[TBL] [Abstract][Full Text] [Related]
23. Vinorelbine, ifosfamide, and cisplatin combination as salvage chemotherapy in advanced non-small cell lung cancer.
Song SY; Kim WS; Kim K; Jung CW; Im YH; Kim HJ; Kang WK; Lee HG; Kwon OJ; Rhee CH; Park CH; Park K
Jpn J Clin Oncol; 2003 Oct; 33(10):509-13. PubMed ID: 14623918
[TBL] [Abstract][Full Text] [Related]
24. Weekly docetaxel with either gemcitabine or vinorelbine as second-line treatment in patients with advanced nonsmall cell lung carcinoma: Phase II trials of the Minnie Pearl Cancer Research Network.
Hainsworth JD; Burris HA; Billings FT; Bradof JE; Baker M; Greco FA
Cancer; 2001 Nov; 92(9):2391-8. PubMed ID: 11745295
[TBL] [Abstract][Full Text] [Related]
25. Gemcitabine and vinorelbine in advanced nonsmall cell lung carcinoma: a phase II study.
Lilenbaum R; Cano R; Schwartz M; Siegel L; Lutzky J; Lewis M; Krill E; Barreras L; Davila E
Cancer; 2000 Feb; 88(3):557-62. PubMed ID: 10649247
[TBL] [Abstract][Full Text] [Related]
26. Options in advanced non-small cell lung cancer: a review and report on a phase II study of vinorelbine plus gemcitabine.
Lilenbaum R
Oncologist; 2001; 6 Suppl 1():16-9. PubMed ID: 11182000
[TBL] [Abstract][Full Text] [Related]
27. Integrating concurrent navelbine and cisplatin to hyperfractionated radiotherapy in locally advanced non-small cell lung cancer patients treated with induction and consolidation chemotherapy: feasibility and activity results.
Reguart N; Viñolas N; Casas F; Gimferrer JM; Agustí C; Molina R; Martin-Richard M; Sanchez-Reyes A; Gascón P
Lung Cancer; 2004 Jul; 45(1):67-75. PubMed ID: 15196736
[TBL] [Abstract][Full Text] [Related]
28. Gemcitabine, vinorelbine, and Cisplatin in the treatment of advanced nonsmall cell lung cancer.
Hasturk S; Hatabay N; Ece F; Karatasli M; Hanta I
Am J Clin Oncol; 2009 Jun; 32(3):280-5. PubMed ID: 19433960
[TBL] [Abstract][Full Text] [Related]
29. Sequential therapy in advanced non-small-cell lung cancer with weekly paclitaxel followed by cisplatin-gemcitabine-vinorelbine. A phase II study.
Feliu J; Martin G; Lizón J; Chacón JI; Dorta J; de Castro J; Rodríguez A; Sánchez Heras B; Torrego JC; Espinosa E; González Barón M;
Ann Oncol; 2001 Oct; 12(10):1369-74. PubMed ID: 11762806
[TBL] [Abstract][Full Text] [Related]
30. Gemcitabine, vinorelbine and cisplatin combination chemotherapy in advanced non-small cell lung cancer: a phase II trial.
Laack E; Mende T; Dürk H; Kneba M; Dickgreber N; Welte T; Müller T; Scholtze J; Graeven U; Jasiewicz Y; Edler L; Hossfeld DK
Eur J Cancer; 2002 Mar; 38(5):654-60. PubMed ID: 11916547
[TBL] [Abstract][Full Text] [Related]
31. Vinorelbine-gemcitabine in advanced non-small-cell lung cancer (NSCLC): an AASLC phase II trial. Austrian Association for the Study of Lung Cancer.
Krajnik G; Mohn-Staudner A; Thaler J; Greil R; Schmeikal S; Marhold F; Deutsch J; Preiss P; Malayeri R; Schäfer-Prokop C; Wein W; Huber H; Pirker R
Ann Oncol; 2000 Aug; 11(8):993-8. PubMed ID: 11038036
[TBL] [Abstract][Full Text] [Related]
32. Phase I/II study of gemcitabine plus vinorelbine as first-line chemotherapy of non-small-cell lung cancer.
Lorusso V; Carpagnano F; Frasci G; Panza N; Di Rienzo G; Cisternino ML; Napoli G; Orlando S; Cinieri S; Brunetti C; Palazzo S; De Lena M
J Clin Oncol; 2000 Jan; 18(2):405-11. PubMed ID: 10637256
[TBL] [Abstract][Full Text] [Related]
33. Gemcitabine and vinorelbine as first-line chemotherapy for advanced non-small cell lung cancer: a phase II trial.
Laack E; Mende T; Benk J; Chemaissani A; Scholtze J; Lorenz C; Niestroy A; Dalhoff K; Müller T; Walter T; Dürk H; Edler L; Hossfeld DK
Eur J Cancer; 2001 Mar; 37(5):583-90. PubMed ID: 11290433
[TBL] [Abstract][Full Text] [Related]
34. Phase II study with gemcitabine, ifosfamide and cisplatin in advanced non-small cell lung cancer.
Chen YM; Perng RP; Whang-Peng J; Wu HW; Lin WC; Tsai CM
Lung Cancer; 2000 Dec; 30(3):199-202. PubMed ID: 11137205
[TBL] [Abstract][Full Text] [Related]
35. Phase II study of vinorelbine/ifosfamide/cisplatin for the treatment of advanced non-small-cell lung cancer.
Baldini E; Tibaldi C; Chella A; Angeletti CA; Silvano G; Andrei A; Algeri R; Conte PF
Ann Oncol; 1996 Sep; 7(7):747-9. PubMed ID: 8905035
[TBL] [Abstract][Full Text] [Related]
36. Multicentre randomised phase III study comparing the same dose and schedule of cisplatin plus the same schedule of vinorelbine or gemcitabine in advanced non-small cell lung cancer.
Martoni A; Marino A; Sperandi F; Giaquinta S; Di Fabio F; Melotti B; Guaraldi M; Palomba G; Preti P; Petralia A; Artioli F; Picece V; Farris A; Mantovani L
Eur J Cancer; 2005 Jan; 41(1):81-92. PubMed ID: 15617993
[TBL] [Abstract][Full Text] [Related]
37. Randomized trial comparing cisplatin, gemcitabine, and vinorelbine with either cisplatin and gemcitabine or cisplatin and vinorelbine in advanced non-small-cell lung cancer: interim analysis of a phase III trial of the Southern Italy Cooperative Oncology Group.
Comella P; Frasci G; Panza N; Manzione L; De Cataldis G; Cioffi R; Maiorino L; Micillo E; Lorusso V; Di Rienzo G; Filippelli G; Lamberti A; Natale M; Bilancia D; Nicolella G; Di Nota A; Comella G
J Clin Oncol; 2000 Apr; 18(7):1451-7. PubMed ID: 10735892
[TBL] [Abstract][Full Text] [Related]
38. Triplets versus doublets, with or without cisplatin, in the first-line treatment of stage IIIB-IV non-small cell lung cancer (NSCLC) patients: a multicenter randomised factorial trial (FAST).
Boni C; Tiseo M; Boni L; Baldini E; Recchia F; Barone C; Grossi F; Germano D; Matano E; Marini G; Labianca R; Di Costanzo F; Bagnulo A; Pennucci C; Caroti C; Mencoboni M; Zanelli F; Prochilo T; Cafferata MA; Ardizzoni A;
Br J Cancer; 2012 Feb; 106(4):658-65. PubMed ID: 22240782
[TBL] [Abstract][Full Text] [Related]
39. Phase II study of gemcitabine and vinorelbine combination chemotherapy in patients with non-small-cell lung cancer not responding to previous chemotherapy.
Chen YM; Perng RP; Lee CS; Lin WC; Tsai CM; Whang-Peng J
Am J Clin Oncol; 2003 Dec; 26(6):567-70. PubMed ID: 14663373
[TBL] [Abstract][Full Text] [Related]
40. Gemcitabine plus vinorelbine as first-line chemotherapy in advanced nonsmall cell lung carcinoma a phase II trial.
Bajetta E; Chiara Stani S; De Candis D; Bidoli P; Mariani L; Zilembo N; Pozzi P; Procopio G
Cancer; 2000 Aug; 89(4):763-8. PubMed ID: 10951338
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]